University of Alberta to Study Cannabis Treatment for MS, Alzheimer’s, and Huntington’s
Mon / Dec 9th
Canadian cannabis producer Atlas Biotechnologies has awarded a $300,000 grant to University of Alberta researchers for the investigation of cannabis as a potential therapy for multiple sclerosis (MS), Alzheimer’s disease, and Huntington’s disease.